HomeNewsBusinessEarningsBiocon Q3 PAT seen up 105.4% YoY to Rs. 188.7 cr: ICICI Direct
Trending Topics

Biocon Q3 PAT seen up 105.4% YoY to Rs. 188.7 cr: ICICI Direct

Net Sales are expected to increase by 30.7 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs. 1,382.4 crore, according to ICICI Direct.

January 11, 2019 / 17:26 IST
Story continues below Advertisement
Kiran Mazumdar-Shaw | Company: Chairperson, Biocon | Net worth: $4.6 billion | She added $2.22 billion to her wealth, taking her net worth to $4.6 billion in 2020, from $2.38 billion in 2019. It marked the highest gain in percentage terms at 93.28 percent among India's 100 richest persons. (Image: Reuters)
Kiran Mazumdar-Shaw | Company: Chairperson, Biocon | Net worth: $4.6 billion | She added $2.22 billion to her wealth, taking her net worth to $4.6 billion in 2020, from $2.38 billion in 2019. It marked the highest gain in percentage terms at 93.28 percent among India's 100 richest persons. (Image: Reuters)

ICICI Direct has come out with its third quarter (October-December’ 18) earnings estimates for the Healthcare sector. The brokerage house expects Biocon to report net profit at Rs. 188.7 crore up 105.4% year-on-year (up 13.8% quarter-on-quarter).

Net Sales are expected to increase by 30.7 percent Y-o-Y (up 4.6 percent Q-o-Q) to Rs. 1,382.4 crore, according to ICICI Direct.

Story continues below Advertisement

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 63.3 percent Y-o-Y (up 6.6 percent Q-o-Q) to Rs. 362.1 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.